Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'patients trials'
patients trials published presentations and documents on DocSlides.
Demystifying Clinical Trials: Focusing on Trials with Therapeutic Intent
by tabitha
Ashley E. Ross MD PhD. Executive Medical Director....
Re-randomising patients within clinical trials
by sean858
Tim Morris. MRC Clinical Trials Unit at UCL. 14 Ma...
Mantle Cell Lymphoma Clinical TrialsThe following clinical trials are
by byrne
617TRIALS FOR RELAPSED/REFRACTORY PATIENTS19-021p ...
Optimizing Mobile Clinical Trials by Engaging Patients and Sites
by mia
Leanne Madre, CTTI . Cindy Geoghegan, Individual P...
Broadening Eligibility Criteria to Make Clinical Trials More Representative
by elena
Joint Recommendations of the American Society of C...
Clinical Trials Should NOT Be Stopped Early for Benefit Bas
by test
Group . 6. : . David . Hottman,. . Fatima Khan, ...
Designing Phase I Trials With Targeted Agents:
by giovanna-bartolotta
Challenging Tradition. Chia-Chi (Josh) Lin, MD, P...
Central Statistical Monitoring in Clinical Trials
by ellena-manuel
Amy Kirkwood. Statistician. CR UK and UCL Cancer ...
Why African Americans Must Understand and Participate in Clinical Trials and Vaccines
by ryotheasy
Virginia A. Caine, M.D.. Associate Professor of Me...
Lesson 3: Clinical Trials
by margaret
Module 3: The Basics of Health Care. Oncology Pati...
Cancer Trials 30 years in the making
by dorothy
Professor John . Simes. Director, NHMRC Clinical T...
Return on investment of clinical trials
by bethany
Associate Professor Rachael Morton. Director of He...
Clinical Trials in India
by jainy
History, Current Regulations , and Future Conside...
Global reach for Australian trials
by sadie
Anna Nowak. MBBS FRACP PhD. Chair, . CoOperative. ...
Clinical Trials in DMD
by margaret
Marina Di Marco. Principal Neuromuscular Physiothe...
Canadian Cancer Trials Group
by violet
“Who We Are & Where We Are Going”. 2022 Ne...
Multi-centre trials in Orthopaedic Oncology:
by phoebe-click
Dream or Reality?. Michelle Ghert, MD, FRCSC. Ass...
Drug Development : Basic
by myesha-ticknor
Overview of Clinical Trials. : Phase I-III. Patr...
LSU Journal Club Efficacy and Safety of
by trish-goza
Evolocumab. in. Reducing Lipids and Cardiovascul...
Primary Prevention: Progress but a long way to go
by windbey
Lawrence J. Fine, MD, . DrPH. , . FAHA. Division ....
The Agency for Healthcare Research and Quality has not yet seen or ap
by della
IntroductionStudy Selection..........................
Roger Chou MD Mark Helfand MD MPH Susan Carson MPH Oregon Evidence
by evelyn
Introduction Study Selection ...
Conducting clinical trials -
by gagnon
new evidence to improve patient . care. Dr . Isla ...
Clinical Trials Oct . 6, Lyon France
by wayne461
Birthe Lemley. Executive. Board . Member. of ENG...
Improving recruitment to clinical trials through closer respiratory monitoring in ALS/MND
by zayne
Jo Borrelli, Claire Tucak, Sue Walters. Perron Ins...
Performance in Initiating and Delivering Clinical Research
by tawny-fly
Why are we doing this?. . Reporting Period . Q1 ...
Randomized Control
by natalia-silvester
trials. Kinza Waqar. Assisitant. Clinical Resear...
Drug development
by lindy-dunigan
. Recognise the use of plants as sources of medi...
Phase I trials: A New era in
by mitsue-stanley
OnCology. drug development. Jan 22, 2015. Method...
Does taking
by karlyn-bohler
probiotics. routinely with antibiotics. prevent ...
Performance in Initiating and Delivering Clinical Research
by calandra-battersby
Why are we doing this?. . Through the NIHR (Nati...
Developing Better Medicines at Lower
by tatiana-dople
Costs: The . Good Pharma Model. Speaker:. Donald ...
Should I Enroll in a Clinical Trial?
by tatyana-admore
David N. Assis, MD. Assistant Professor of Medici...
Peter Fisher FRCP, FFHom
by olivia-moreira
Director of Research. Royal London Hospital for I...
Topics in Clinical Trials (6
by olivia-moreira
) - 2012. J. Jack Lee, Ph.D.. Department of Biost...
Precision Medicine: Levels of Evidence Required for Reporting Variants and Guiding Patient Treatmen
by ellena-manuel
Apostolia M. Tsimberidou, . MD, PhD. Professor . ...
Biomarkers in Phase II designs in cancer clinical trials
by conchita-marotz
Methods in Clinical Cancer Research. February 12,...
Design of Clinical Trials
by faustina-dinatale
Robert Temple, M.D.. Food and Drug Administration...
What Has Been Tried and What Is True?
by celsa-spraggs
What Has Changed?. Less Stent Thrombosis . With. ...
Balancing the practical implications of adaptive designs with the statistical benefits
by stefany-barnette
Mahesh Parmar. MRC . Clinical Trials Unit at . UC...
Load More...